AKI-Sapere- a novel prognostic of Acute Kidney Injury due to cardiac surgery

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

• Measuring cellular senescence to predict and prevent peripheral neuropathy
• AKI-Sapere- a novel prognostic of Acute Kidney Injury due to cardiac surgery
• Development of biomarker of aging as predictor of AKI due to cardiac surgery
• A biomarker of aging as a predictor of kidney transplant function

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

• Evaluate the Safety, Tolerability, and Immunogenicity of Adjuvanted Preventive Dual Aβ/tau Vaccine, Duvax in Healthy Volunteers
• A Drug Discovery Platform to Prioritize Development of Natural Product Neuromodulators for Treating Cognitive Impairment
• VR-CARES: Feasibility of Virtual Reality for Caregiver Assembly, Relief, Empowerment, and Support to improve social connection, health, and at-home dementia care
• Developing an Integrated Brain State Monitor for Personalized Anesthesia Decision Support: Preventing Postoperative Delirium in Elderly and Patients At Risk for Alzheimer's or Related Dementias
• Lead Optimization of a Therapeutic Candidate for Alzheimer’s Disease

Research funding history

5 SBIR/STTR records share this UEI (2014–2021). Reported award amounts total $4,121,162. Reported amounts are not federal obligations.

Phases: Phase I, Phase II – Direct to Phase II, Phase II

Agencies: Department of Health and Human Services

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards